These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 7473878)
1. Alteration of corticotropin-releasing factor immunoreactivity in MPTP-treated rats. Huang CC; Lee EH J Neurosci Res; 1995 Jul; 41(4):471-80. PubMed ID: 7473878 [TBL] [Abstract][Full Text] [Related]
2. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres. Henry BA; Lightman SL; Lowry CA J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765 [TBL] [Abstract][Full Text] [Related]
3. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Sakamoto F; Yamada S; Ueta Y Regul Pept; 2004 May; 118(3):183-91. PubMed ID: 15003835 [TBL] [Abstract][Full Text] [Related]
4. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew. Kozicz T; Bordewin LA; Czéh B; Fuchs E; Roubos EW Psychoneuroendocrinology; 2008 Jul; 33(6):741-54. PubMed ID: 18394812 [TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
6. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by lipopolysaccharide of naloxone-induced luteinising hormone secretion is accompanied by increases in corticotropin-releasing factor immunoreactivity in hypothalamic paraventricular neurones in female rats. He D; Akema T J Neuroendocrinol; 2005 Feb; 17(2):67-72. PubMed ID: 15796756 [TBL] [Abstract][Full Text] [Related]
8. Excitatory stimulation of neurons in the arcuate nucleus initiates central CRF-dependent stimulation of colonic propulsion in rats. Tebbe JJ; Pasat IR; Mönnikes H; Ritter M; Kobelt P; Schäfer MK Brain Res; 2005 Mar; 1036(1-2):130-8. PubMed ID: 15725410 [TBL] [Abstract][Full Text] [Related]
9. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats. Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379 [TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325 [TBL] [Abstract][Full Text] [Related]
12. Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala. Choi SH; Kim SJ; Park SH; Moon BH; Do E; Chun BG; Lee MS; Shin KH Peptides; 2005 Nov; 26(11):2246-51. PubMed ID: 16269353 [TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference. Hwang BH; Stewart R; Zhang JK; Lumeng L; Li TK Brain Res; 2004 Nov; 1026(1):143-50. PubMed ID: 15476706 [TBL] [Abstract][Full Text] [Related]
14. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Rivier C; Lee S Brain Res; 1996 Jul; 726(1-2):1-10. PubMed ID: 8836539 [TBL] [Abstract][Full Text] [Related]
15. Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Yokota M; Ozaki Y; Sakamoto F; Yamada S; Saito J; Fujihara H; Ueta Y Stress; 2004 Jun; 7(2):109-12. PubMed ID: 15512854 [TBL] [Abstract][Full Text] [Related]
16. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Lee S; Schmidt ED; Tilders FJ; Rivier C Alcohol Clin Exp Res; 2001 Jan; 25(1):98-105. PubMed ID: 11198721 [TBL] [Abstract][Full Text] [Related]